S. African COVID variant better at bypassing Pfizer/BioNTech jab: Israeli study
The impact of chemotherapy on immune cells in the tumor microenvironment
11 April 2021CPR training offered to just over half of surveyed ON high school students despite mandated training
12 April 2021S. African COVID variant better at bypassing Pfizer/BioNTech jab: Israeli study
The South African coronavirus variant is better at “breaking through” the defences of the Pfizer/BioNTech vaccine than other forms of the virus, Israeli experts said Sunday.
